Published in Lab Business Week, September 23rd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Kiadis.
Report 1: Oncology focused pharmaceutical product development company Kiadis Pharma announced today that the European Agency for the Evaluation of Medicinal Products (EMEA) has granted the company the SME (Small and Medium Sized Enterprises) status. This status for medical companies provides access to provisions for administrative and financial assistance. Kiadis Pharma will use this status to support the development of novel treatments for significant unmet medical needs in the field of bone marrow...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.